Prevention of liver fibrosis and steatosis progression among heavy drinkers with and without HIV after 30-day drinking-reduction program
View ORCID ProfileSeungjun Ahn, Veronica Richards, Emmanuel Thomas, Dushyantha Jayaweera, Varan Govind, Zhigang Li, Ronald A. Cohen, Robert L. Cook
doi: https://doi.org/10.1101/2023.02.27.23286532
Seungjun Ahn
1Department of Biostatistics, University of Florida, Gainesville, FL 32611, U.S.A.
3Southern HIV and Alcohol Research Consortium, Emerging Pathogens Institute, Gainesville, FL 32610, U.S.A.
Veronica Richards
2Department of Epidemiology, University of Florida, Gainesville, FL 32611, U.S.A.
3Southern HIV and Alcohol Research Consortium, Emerging Pathogens Institute, Gainesville, FL 32610, U.S.A.
7Edna Bennett Pierce Prevention Research Center, Pennsylvania State University, University Park, PA 16802, U.S.A.
Emmanuel Thomas
4Schiff Center for Liver Disease, University of Miami Miller School of Medicine, Miami, FL 33136, U.S.A.
Dushyantha Jayaweera
4Schiff Center for Liver Disease, University of Miami Miller School of Medicine, Miami, FL 33136, U.S.A.
Varan Govind
6Department of Radiology, University of Miami Miller School of Medicine, Miami, FL 33136, U.S.A.
Zhigang Li
1Department of Biostatistics, University of Florida, Gainesville, FL 32611, U.S.A.
3Southern HIV and Alcohol Research Consortium, Emerging Pathogens Institute, Gainesville, FL 32610, U.S.A.
Ronald A. Cohen
3Southern HIV and Alcohol Research Consortium, Emerging Pathogens Institute, Gainesville, FL 32610, U.S.A.
5Department of Clinical and Health Psychology, University of Florida, Gainesville, FL 32610, U.S.A.
Robert L. Cook
2Department of Epidemiology, University of Florida, Gainesville, FL 32611, U.S.A.
3Southern HIV and Alcohol Research Consortium, Emerging Pathogens Institute, Gainesville, FL 32610, U.S.A.
Article usage
Posted March 01, 2023.
Prevention of liver fibrosis and steatosis progression among heavy drinkers with and without HIV after 30-day drinking-reduction program
Seungjun Ahn, Veronica Richards, Emmanuel Thomas, Dushyantha Jayaweera, Varan Govind, Zhigang Li, Ronald A. Cohen, Robert L. Cook
medRxiv 2023.02.27.23286532; doi: https://doi.org/10.1101/2023.02.27.23286532
Prevention of liver fibrosis and steatosis progression among heavy drinkers with and without HIV after 30-day drinking-reduction program
Seungjun Ahn, Veronica Richards, Emmanuel Thomas, Dushyantha Jayaweera, Varan Govind, Zhigang Li, Ronald A. Cohen, Robert L. Cook
medRxiv 2023.02.27.23286532; doi: https://doi.org/10.1101/2023.02.27.23286532
Subject Area
Subject Areas
- Addiction Medicine (405)
- Allergy and Immunology (716)
- Anesthesia (210)
- Cardiovascular Medicine (2995)
- Dermatology (254)
- Emergency Medicine (447)
- Epidemiology (12887)
- Forensic Medicine (12)
- Gastroenterology (840)
- Genetic and Genomic Medicine (4679)
- Geriatric Medicine (429)
- Health Economics (738)
- Health Informatics (2976)
- Health Policy (1080)
- Hematology (396)
- HIV/AIDS (942)
- Medical Education (436)
- Medical Ethics (116)
- Nephrology (479)
- Neurology (4465)
- Nursing (239)
- Nutrition (655)
- Oncology (2321)
- Ophthalmology (659)
- Orthopedics (261)
- Otolaryngology (330)
- Pain Medicine (289)
- Palliative Medicine (85)
- Pathology (506)
- Pediatrics (1210)
- Primary Care Research (507)
- Public and Global Health (7058)
- Radiology and Imaging (1568)
- Respiratory Medicine (930)
- Rheumatology (447)
- Sports Medicine (389)
- Surgery (495)
- Toxicology (61)
- Transplantation (214)
- Urology (186)